Salarius: 3Q Earnings Snapshot
BOSTON (AP) _ Salarius Pharmaceuticals, Inc. (SLRX) on Wednesday reported a loss of $2.6 million in its third quarter.
The Boston-based company said it had a loss of 73 cents per share. Losses, adjusted for non-recurring gains and to account for discontinued operations, came to $1.04 per share.
The biotech drug developer posted revenue of $874,900 in the period. Its adjusted revenue was $875,000.
Salarius shares have fallen 33% since the beginning of the year. The stock has decreased 53% in the last 12 months.